TW200517143A - Process for producing the treatment of a variety of cardiovascular disorders cotherapy drugs and products produced thereby - Google Patents

Process for producing the treatment of a variety of cardiovascular disorders cotherapy drugs and products produced thereby

Info

Publication number
TW200517143A
TW200517143A TW092133326A TW92133326A TW200517143A TW 200517143 A TW200517143 A TW 200517143A TW 092133326 A TW092133326 A TW 092133326A TW 92133326 A TW92133326 A TW 92133326A TW 200517143 A TW200517143 A TW 200517143A
Authority
TW
Taiwan
Prior art keywords
producing
cotherapy
drugs
variety
treatment
Prior art date
Application number
TW092133326A
Other languages
Chinese (zh)
Other versions
TWI319712B (en
Inventor
Yu-Fang Hu
Yao-Kun Huang
Original Assignee
Tty Biopharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tty Biopharm Co Ltd filed Critical Tty Biopharm Co Ltd
Priority to TW92133326A priority Critical patent/TWI319712B/en
Publication of TW200517143A publication Critical patent/TW200517143A/en
Application granted granted Critical
Publication of TWI319712B publication Critical patent/TWI319712B/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

This invention discloses a method for producing solid form of drug for treating cardiovascular diseases in compound prescription, comprising (a) adding at least two kinds of active compounds and a pharmaceutically acceptable excipient into an appropriate container synchronously for well mixing to form a mixture; (b) performing solid formation of the mixture to obtain the compound prescription for treating cardiovascular diseases. The step (a) further comprises mixing at least two kinds of active compounds and extender, surfactant, binder, disintegrating agent or lubricant. The tablet dosage form can be cut half for clinical use, if necessary. This invention also relates to a medicine prepared from the above method.
TW92133326A 2003-11-27 2003-11-27 Process for producing solid dosage forms of combination medicine for treating cardiovascular disorders and stable combination medicine thereby TWI319712B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW92133326A TWI319712B (en) 2003-11-27 2003-11-27 Process for producing solid dosage forms of combination medicine for treating cardiovascular disorders and stable combination medicine thereby

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW92133326A TWI319712B (en) 2003-11-27 2003-11-27 Process for producing solid dosage forms of combination medicine for treating cardiovascular disorders and stable combination medicine thereby

Publications (2)

Publication Number Publication Date
TW200517143A true TW200517143A (en) 2005-06-01
TWI319712B TWI319712B (en) 2010-01-21

Family

ID=45073657

Family Applications (1)

Application Number Title Priority Date Filing Date
TW92133326A TWI319712B (en) 2003-11-27 2003-11-27 Process for producing solid dosage forms of combination medicine for treating cardiovascular disorders and stable combination medicine thereby

Country Status (1)

Country Link
TW (1) TWI319712B (en)

Also Published As

Publication number Publication date
TWI319712B (en) 2010-01-21

Similar Documents

Publication Publication Date Title
Das et al. A survey of the structures of US FDA approved combination drugs
HUP0401344A2 (en) Pharmaceutical compositions to prevent abuse of opioids and process for producing them
WO2004105702A3 (en) Foamable pharmaceutical compositions and methods for treating a disorder
WO2004071529A3 (en) Uses of anti-insulin-like growth factor i receptor antibodies
EP1651195A4 (en) Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
HUP9904094A2 (en) Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent
HK1099511A1 (en) Method for the production of an administration form which is secured against misuse
WO2005065185A3 (en) Temperature-stable formulations, and methods of development thereof
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
EP1595533A4 (en) Tablet quickly melting in oral cavity
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
WO2004045593A3 (en) Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
MXPA05012810A (en) Memantine oral dosage forms.
ATE438383T1 (en) METHOD FOR PRODUCING TANNATE TABLETS, CAPSULES OR OTHER SOLID DOSAGE FORMS
CN102300562A (en) Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives
WO2002087596A3 (en) Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases
WO2006138317A3 (en) Dosage regimen for prasugrel
RS89904A (en) Medicaments containing steroids and a novel anticholinesterase drug
TW200517143A (en) Process for producing the treatment of a variety of cardiovascular disorders cotherapy drugs and products produced thereby
TW200509984A (en) Injectable dosage form of flupirtine
TW200502236A (en) Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
BR0307703A (en) Drug compositions based on anticholinergic agents and egfr kinase inhibitors
DE60100431T2 (en) COMBINATION OF MEDICINAL PRODUCTS FOR TREATING HEADACHE WITH MIRTAZAPINE AND PARACETAMOL OR NON-STEROID ANTI-FLAMMING AGENTS
WO2002053099A3 (en) Methods and compositions for treating periodontal disease
ATE259223T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING A NO DONOR AND THERAPEUTIC USE THEREOF

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent